Mortality and Pre-Hospitalization use of Renin-Angiotensin System Inhibitors in Hypertensive COVID-19 Patients

Chen, C; Wang, F; Chen, P; Jiang, JG; Cui, GL; Zhou, N; Moroni, F; Moslehi, JJ; Ammirati, E; Wang, DW

Ammirati, E (corresponding author), ASST Grande Osped Metropolitano Niguarda, De Gasperis Cardio Ctr, Piazza Osped Maggiore 3, I-20162 Milan, Italy.; Ammirati, E (corresponding author), ASST Grande Osped Metropolitano Niguarda, Transplant Ctr, Piazza Osped Maggiore 3, I-20162 Milan, Italy.; Wang, DW (corresponding author), Huazhong Univ Sci & Technol, Div Cardiol, Dept Internal Med, Tongji Hosp,Tongji Med Coll, 1095 Jiefang Ave, Wuhan 430030, Peoples R China.

JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020; 9 (21):

Abstract

Background There has been significant controversy regarding the effects of pre-hospitalization use of renin-angiotensin system (RAS) inhibitors on the......

Full Text Link